A detailed history of Tyche Wealth Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 4,750 shares of BMY stock, worth $276,592. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,750
Previous 5,741 17.26%
Holding current value
$276,592
Previous $238 Million 3.09%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$39.66 - $51.75 $39,303 - $51,284
-991 Reduced 17.26%
4,750 $246 Million
Q2 2024

Jul 18, 2024

SELL
$40.25 - $52.99 $36,305 - $47,796
-902 Reduced 13.58%
5,741 $238 Million
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $7,388 - $8,377
-154 Reduced 2.27%
6,643 $360 Million
Q4 2023

Jan 30, 2024

BUY
$48.48 - $57.85 $329,518 - $393,206
6,797 New
6,797 $349 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tyche Wealth Partners LLC Portfolio

Follow Tyche Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyche Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tyche Wealth Partners LLC with notifications on news.